These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8988527)

  • 1. Evaluation and treatment of low responders.
    Scott RT
    Semin Reprod Endocrinol; 1996 Nov; 14(4):317-37. PubMed ID: 8988527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
    D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
    Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
    Jain T; Soules MR; Collins JA
    Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
    Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
    Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction in the ovulatory woman.
    Silverberg KM
    Semin Reprod Endocrinol; 1996 Nov; 14(4):339-44. PubMed ID: 8988528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
    Elnashar A; Fouad H; Eldosoky M; Saeid N
    Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H; Sezik M; Ozkaya O
    J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?
    Palomba S; Orio F; Falbo A; Russo T; Lombardi G; Zullo F
    Hum Reprod; 2004 Nov; 19(11):2682-3; author reply 2683. PubMed ID: 15496601
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New advances in ovulation induction.
    Kafy S; Tulandi T
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):248-52. PubMed ID: 17495641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL; Farhi J; Homburg R; Jacobs HS
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive toxicity of ovulation induction.
    Tucker KE
    Semin Reprod Endocrinol; 1996 Nov; 14(4):345-53. PubMed ID: 8988529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
    Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
    Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
    Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
    Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.